COVID-19
An Introduction to COVID-19
On March 11th 2020 the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line but also those navigating patient treatment during this unprecedented situation.
The touchRESPIRATORY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
In this episode, Professor Irene Higginson, Director of Better Health and Care Futures at King’s College London, discusses the complex challenges of managing breathlessness. She explores non-pharmacological strategies, the value of multidisciplinary care, and how the Breathlessness Support Services at KCL are transforming patient support. Tune in for expert insights and a look at future directions in breathlessness research and care.
The COVA study (NCT04472728) was a double-blind, placebo-controlled phase 2 to 3 study that investigated BIO101 for the prevention of respiratory deterioration in hospitalized COVID-19. touchRESPIRATORY were delighted to speak with Dr. Girish B. Nair (Beaumont Health, Royal Oak, MI, USA) around ...
Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this ...
Dr Paula K Skarda is a hospitalist and primary internist and works for HealthPartners and Regions Hospital in Minnesota, USA. She has been in practice for 25 years after graduating from the University of Minnesota Medical School and completing the MedPeds ...
The IPCRG COVID-19 and Respiratory Q&A is providing evidence based COVID and respiratory advice to practising primary care clinicians. Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) answers questions from the Q&A on managing COVID-19, ...
touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments ...
The COVID-19 pandemic remains an international public health emergency, and the emergence of new SARS-CoV-2 variants highlights concerns regarding COVID-19 breakthrough infections. Understanding emerging SARS-CoV-2 variants is especially important as the medical and public health community seeks to contain COVID-19. ...
INVENT COVID was a phase II study, which investigated the efficacy and safety of intravenous imatinib in acute respiratory distress syndrome induced by COVID-19 (Clinical Trials Identifier: NCT04794088). touchRESPIRATORY were delighted to speak with Dr. Leila Atmowihardjo (Amsterdam Medical Centers: ...
This analysis of COVIDENCE UK investigated potential sociodemographic, behavioural, clinical, pharmacological and nutritional determinants of antibody responses to administration of SARS-CoV-2 vaccination and booster doses. It was a pleasure to talk with Professor Adrian Martineau (Queen Mary University of London, ...
CORONAVIT was a phase 3 randomized controlled trial, investigating the potential of vitamin D to reduce incidence and severity of acute respiratory infections (ARI) and COVID-19. touchRESPIRATORY were delighted to speak with Professor Adrian Martineau (Queen Mary University of London, London, ...
Sabizabulin is a microtubule disruptor initially developed as an anti-cancer agent that is being repurposed to treat COVID-19. The VERU-111 clinical trial (NCT04842747), which investigates the use of oral sabizabulin on hospitalized patients with COVID-19, is discussed in this touchRESPIRATORY ...
We were delighted to speak to Dr. Erik Duijvelaar (Amsterdam University Medical Center, Amsterdam, the Netherlands) around the cardiac safety findings from the CounterCOVID study, investigating imatinib for the treatment of COVID-19. The abstract 'Cardiac Safety of Imatinib for the ...
touchRESPIRATORY caught up with Prof. Linda L Chlan (Associate Dean for Nursing Research and Professor of Nursing, Mayo Clinic, Rochester, MN, USA) to discuss the findings from a study on the impact of the COVID-19 pandemic on patient accrual in ...
It was a pleasure to talk with Prof. Linda L Chlan (Associate Dean for Nursing Research and Professor of Nursing, Mayo Clinic, Rochester, MN, USA) to learn more around the challenges of enrolling patients in clinical trials prior to the ...
touchRESPIRATORY were delighted to speak with Dr. Patrick Lyons (Washington University School of Medicine, St. Louis, MO, USA) to discuss the outcomes from using corticosteroids as a treatment for the distinct subphenotypes of SARS-CoV-2 pneumonia. The abstract 'Novel EHR-Derived SARS-CoV-2 ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
